BNT327-06: A Phase II/III, multisite, randomized master protocol for a global trial of BNT327 in combination with chemotherapy and other investigational agents in first-line non-small cell lung cancer

Title
A Phase II/III, multisite, randomized master protocol for a global trial of BNT327 in combination with chemotherapy and other investigational agents in first-line non-small cell lung cancer
Principal Investigator
Bhasin, Pooja Gogia
Phase
II/III
Age Group
Adult
Applicable Disease Sites
Lung Cancer
Participating Institutions
Mary Babb Randolph Cancer Center
Contacts
Rachel Harper
Clinical Research Specialist
Phone: +1 304-293-6066
Email:

View on ClinicalTrials.gov